Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06223867 · ClinicalTrials.gov registry record · NA
Efficacy, Effectiveness, and Implementation of Jaspr Health in Emergency Department- Part A
A NA study of Suicidal Ideation and Suicide Attempt, sponsored by University of Massachusetts, Worcester.
- Recruiting
- Registry status
- NA
- Development phase
- 670
- Enrollment target
- 1
- Study location
NCT06223867: Recruiting NA study of Suicidal Ideation and Suicide Attempt, sponsored by University of Massachusetts, Worcester.
NCT06223867 is a NA study of Suicidal Ideation and Suicide Attempt that is actively recruiting participants, run by University of Massachusetts, Worcester. The registered enrollment target is 670 participants, above the 260-participant average among 84 other Suicidal Ideation trials with a reported enrollment target (158% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06223867, a NA study of Suicidal Ideation and Suicide Attempt, is actively recruiting participants, sponsored by University of Massachusetts, Worcester.
- RECRUITING
- Registry status
- NA
- Development phase
- 670 participants
- Enrollment target
- 1
- Study location
Study Summary
This Study will comprehensively evaluate a multi-component suicide prevention technology (Jaspr Health) that facilitates delivery of suicided-related evidence-based practices (EBPs) while replacing wasted waiting time with productive time in the Emergency Departments (EDs). The EBPs satisfy several key performance elements for systems adopting Zero Suicide. A Complementary Randomized Controlled Trial and Real-World Study for Efficacy, Effectiveness, and Implementation Study Design (CREID) will be used
Primary Outcome
Death by suicide OR suicide-related acute care utilization within 12 months after enrollment
Conditions Studied
Interventions
- DEVICE Jaspr App + JAH
- BEHAVIORAL ETAU
Study Locations (1)
Massachusetts
- UMass Memorial Health - Worcester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 670 participants |
| Start Date | 2024-02-23 |
| Est. Completion | 2028-03-31 |
| Phase | NA |
What NCT06223867 shows while recruiting
NCT06223867 is an interventional study that assigns participants to a tested intervention. The registered 670 participants enrollment target is mid-sized for trials with a published cap, above the 260-participant average among 84 other Suicidal Ideation trials with a reported enrollment target (158% higher).
The record links to 3 conditions, with Suicidal Ideation appearing as the primary indexed condition, and to 2 interventions - of which Jaspr App + JAH is the first listed.
NCT06223867 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT06223867 about?
NCT06223867 is a clinical study titled "Efficacy, Effectiveness, and Implementation of Jaspr Health in Emergency Department- Part A". This Study will comprehensively evaluate a multi-component suicide prevention technology (Jaspr Health) that facilitates delivery of suicided-related evidence-based practices (EBPs) while replacing wasted waiting time with productive time in the Emergency Departments (EDs). The EBPs satisfy several ...
What is the current status of trial NCT06223867?
This trial is currently recruiting. It is a NA study. The enrollment target is 670 participants. The study started on 2024-02-23. Estimated completion is 2028-03-31.
What conditions does trial NCT06223867 study?
This clinical trial studies the following conditions: Suicidal Ideation, Suicide Attempt, Self Harm.
What interventions are being tested in trial NCT06223867?
The interventions under investigation include: Jaspr App + JAH (DEVICE), ETAU (BEHAVIORAL).
Who is sponsoring clinical trial NCT06223867?
This trial is sponsored by University of Massachusetts, Worcester, which has 240 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06223867 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Suicidal Ideation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06223867's enrollment target sits among peer trials
670 10th of 84 higher than 75 of 84 other Suicidal Ideation trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Suicidal Ideation trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Randomized Clinical Trial of Supplementing Brief Psychotherapy With a Mobile App
RECRUITING · NA
-
Inhibitory Mechanisms of Negative Urgency in Adolescent Suicidal Behavior
RECRUITING · NA
-
Augmenting Massed Cognitive Processing Therapy (CPT) to Prevent Suicide Risk Among Patients With PTSD
RECRUITING · NA
-
Crisis Response Planning for Military Personnel
RECRUITING · NA
-
Suicide Intervention for Alaska Native Youth
RECRUITING · NA
-
Enhancing the Effectiveness of Prolonged Exposure Among Suicidal Individuals With PTSD
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02984761 · 670 participants · NA
Veterans Affairs Lung Cancer Surgery Or Stereotactic Radiotherapy
- NCT05727904 · 670 participants · Phase 3
Study to Investigate Lifileucel Regimen Plus Pembrolizumab Compared With Pembrolizumab Alone in Participants With Untreated Advanced Melanoma.
- NCT07184944 · 671 participants · Phase 3
A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
- NCT07185009 · 671 participants · Phase 3
A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI